[Progress in antiparasitic therapy in South America, with special reference to Brazil].
D000438:Alcohols / Q000627:therapeutic use; D000871:Anthelmintics / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000962:Antimalarials / Q000627:therapeutic use*; D001938:Brazil; D005021:Ethylamines / Q000627:therapeutic use; D006373:Helminthiasis / Q000188:drug therapy; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008154:Lucanthone / Q000627:therapeutic use; D008288:Malaria / Q000188:drug therapy; D008558:Melphalan / Q000627:therapeutic use; D009534:Niclosamide / Q000627:therapeutic use; D010272:Parasitic Diseases / Q000188:drug therapy*; D011528:Protozoan Infections / Q000188:drug therapy; D012457:Salicylamides / Q000627:therapeutic use; D012552:Schistosomiasis / Q000188:drug therapy; D013449:Sulfonamides / Q000627:therapeutic use*; D013729:Terpenes / Q000627:therapeutic use; D014966:Xanthenes / Q000627:therapeutic use
D000438:Alcohols; D000871:Anthelmintics; D000890:Anti-Infective Agents; D000962:Antimalarials; D005021:Ethylamines; D007093:Imidazoles; D012457:Salicylamides; D013449:Sulfonamides; D013729:Terpenes; D014966:Xanthenes; D009534:Niclosamide; D008154:Lucanthone; D008558:Melphalan
Progressi di terapia antiparassitaria nel sud America, con particolare riguardo al Brasile.